In addition to ChREBP regulating the expression of genes related to glucose and lipid metabolism, literature has shown that this transcriptional factor helps induce hepatic steatosis, in combination with other related complications like dyslipidemia and glucose intolerance [35, 36]. The gene discussed is MLXIPL; the disease is fatty liver disease.